Director Hagenbuch buys 1,200 shares of HQI at $14.53; stock now $14.36 after -15.6% decline from 52-week high.
Director Lawrence F. Hagenbuch purchased 1,200 shares at $14.53 on 2024-11-12, increasing his holdings to 109,473 shares. However, the purchase occurred near an interim resistance level—the stock is currently trading at $14.36, down -15.6% from its 52-week high of $17.02, and it sits well above its 52-week low of $11.64. This buy follows a concerning pattern: Hagenbuch's prior two purchases at HQI (on 2023-12-19 and 2023-08-15) both resulted in negative 90-day returns of -24.9% and -34.6% respectively, with a 0% win rate on same-ticker trades over the 90-day measurement window. More broadly, his cross-ticker track record shows 2 prior buys with an average 90-day return of -29.8%, indicating a persistent struggle with trade timing. The company itself presents mixed fundamentals: while annual revenue growth is strong at +22.4%, the latest quarter reports a net loss of $-2.2M on revenue of $9.4M, and the elevated P/E of 143.60 reflects valuation stretched against earnings. This purchase does not reverse the pattern of unsuccessful prior acquisitions at this ticker.